Rhumatologue

Professeur THIERRY SCHAEVERBEKE

📍 Bordeaux (33)HospitalierRPPS 10004420518

📊 Reconnaissance scientifique : 60/100📝 464 articles publiés📚 HAL (8)🎓 6 thèses dirigées

✨ Profil synthétique

IA · 29/04/2026

Le Professeur Thierry Schaeverbeke est un rhumatologue hospitalier à Bordeaux, avec une production scientifique importante (462 publications, h-index de 60). Ses recherches portent principalement sur les maladies auto-immunes et inflammatoires, notamment la polyarthrite rhumatoïde, les spondyloarthropathies et le lupus érythémateux systémique. Il a dirigé plusieurs thèses de doctorat dans des domaines tels que la microbiologie-immunologie et la médecine.

Expertises présumées

Rheumatoid Arthritis
Spondyloarthritis
Systemic Lupus Erythematosus
Autoimmune and Inflammatory Disorders
Systemic Sclerosis
Biothérapies non-anti-TNF
Thérapies anti-TNF
csDMARDs

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

DES Rhumatologie
Rhumatologie (SM)

🎓 Diplômes

DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Thèses universitaires

Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.

Direction de thèses

🎓 6 thèses dirigées

Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

h articles cités ≥ h fois chacun. Un h de 60 = 60 publications avec 60+ citations.

Citations

12 284

Publications

464

i10-index

178

Thématiques principales

Rheumatoid Arthritis Research and Therapies ×207
Spondyloarthritis Studies and Treatments ×82
Systemic Lupus Erythematosus Research ×72
Autoimmune and Inflammatory Disorders Research ×46
Systemic Sclerosis and Related Diseases ×31

Voir sur OpenAlex ↗🆔 ORCID 0000-0002-6976-643X

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

GROUPE HOSPITALIER PELLEGRIN - CHU
Place AMELIE RABA LEON, 33076 Bordeaux
☎ 0556795679Hospitalier🏥 Centre ESPIC ↗

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib 📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Articles de presse (4)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

Un ange gardien pour mieux suivre les maladies chroniques - achat-logistique.info
📰 achat-logistique.info · 12/03/2020
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOX1VFam5MbHZKS2owTlhVUVdBR3A5NWlzOUE0V1AyUjdURHhpNENjcUdHWFdFUFpGRFN0UmhNX21ERThTeUpGdjFtMlp5OEtSWVo3YXZyQnZVTnpJdFNNOUtqZ1dVU3BrakR5QzE1TmQ2Q0ZxOWRsbmswNzl4cVBwZ0ZjRjduZE1LVkpweU1NZ1d2WE1JTUZzY1RvaHN3Q1B4?oc=5" target="_blank">Un ange gar
Maladies inflammatoires chroniques : Ange Gardien, l'application qui veille sur votre santé - Actu.fr
📰 Actu.fr · 09/03/2020
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRVhSSlcta1dPZ0ZqWjAwaUxIRGpjWm1xQy1BWEhxWnFiazVMQ3k1QVhHQlptVGZBYU5uQm9ueEZ2OF9USFMtVW9HUDhTWVpiODVaM1R2SElQWWhlTE9XRXZCQlIwM1Y1SjdVb2QwNzFvN28yLUlxV1I4Q0YxeHBCdUtrM3JmRFl4OXpZNUtVZUJxOTBoNVd5M3pnYXk5Tk1JVDRvU2JlOTlFZmVUa3lqSkpMdFFNZw?oc=
Mal de dos : et si c'était la faute d'une bactérie ? - Le Parisien
📰 Le Parisien · 21/05/2013
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTWpmWFlWbGw2NnlrU1FGcy1jaWFuMjNDbC1PN0dyVlNSdmZIX09lX0x3ZU9HS19Mcmh1c0ZBai05X1VWYUpBOHBmQ2pONkVVZWJ2R0hLSWoyRTAtS3Q3TGtEdnppOGNnTjhwaU84U2pEeW5pRFcxNC0xQlZkRkt2SjVWUEJyZnJGWXViYi02QWpWWHdGWEl0V1gyQzdpRGxDdkk1RjBfczZHZw?oc=5" target="_blan
Bagnères-de-Bigorre. Premières Journées de rhumatologie - ladepeche.fr
📰 ladepeche.fr · 25/02/2013
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNM2cwSkxiNy14OFF1ejZGLV9iNm95NDlFUXoxQmNLQjM2Q0ROcnVHc2l6czU4RHZKYlhMSGttNzNKbHBQVjUyS0lpQkxlNmxPcU5TWEhzckxZbkxMWjFNTU5zZGpGWEx5djNIdmx6M200dEhFdzFNcUJpemJpbVRIUzE0WVZ5ZUFHRVowRmdBRkIwTHQxQVFEVmNZcnktLW1PNzBhZnh6d2JnX2VQRXJxYg?oc=5" targe

Top publications · les plus citées

1
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Annals of the rheumatic diseases · 2021
📚 196 citations🎯 RCR 13.91Top 1% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗
2
Methotrexate and rheumatoid arthritis associated interstitial lung disease
The European respiratory journal · 2021
📚 170 citations🎯 RCR 14.58Top 1% NIH🔓 Open Access📄 PDF gratuit ↗
Lire l'abstract Crossref ↓
Question addressed by the studyMethotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication of RA. Whether MTX exposure increases the risk of ILD in patients with RA is disputed. We aimed to evaluate the association of prior MTX use with development of RA-ILD.MethodsThrough a case–control study design with discovery and international replication samples, we examined the association of MTX exposure with ILD in 410 patients with chronic fibrotic ILD associated with RA (RA-ILD) and 673 patients with RA without ILD. Estimates were pooled over the different samples using meta-analysis techniques.ResultsAnalysis of the discovery sample revealed an inverse relationship between MTX exposure and RA-ILD (adjusted OR 0.46, 95% CI 0.24–0.90; p=0.022), which was confirmed in the replication samples (pooled adjusted OR 0.39, 95% CI 0.19–0.79; p=0.009). The combined estimate using both the derivation and validation samples revealed an adjusted OR of 0.43 (95% CI 0.26–0.69; p=0.0006). MTX ever-users were less frequent among patients with RA-ILD compared to those without ILD, irrespective of chest high-resolution computed tomography pattern. In patients with RA-ILD, ILD detection was significantly delayed in MTX ever-users compared to never-users (11.4±10.4 years and 4.0±7.4 years, respectively; p<0.001).Answer to the questionOur results suggest that MTX use is not associated with an increased risk of RA-ILD in patients with RA, and that ILD was detected later in MTX-treated patients.
3
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
Autoimmunity reviews · 2020
📚 111 citations🎯 RCR 5.86Top 6% NIH

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal27

▼

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease
The European respiratory journal · 2025 · Journal Article
El Husseini K, Lee JS, Juge PA, Ebstein E, et al.
📚 1 cit.🩺 Clinique
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study
Joint bone spine · 2025 · Journal Article
Ladouceur A, Barnetche T, Prey S, Dutriaux C, et al.
📚 4 cit.🩺 Clinique
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
RMD open · 2023 · Observational Study
Ladouceur A, Barnetche T, Mouterde G, Tison A, et al.
📚 5 cit.🩺 Clinique
Correspondence on 'Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting'
Annals of the rheumatic diseases · 2023 · Letter
Scherlinger M, Schaeverbeke T
Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study
Joint bone spine · 2023 · Observational Study
Lopez L, Barnetche T, Galli G, Seneschal J, et al.
📚 9 cit.🎯 RCR 1.70🩺 Clinique
FRENCH-ARRIVE: a serious, evidence-free, and false accusation of unethical research
Lancet (London, England) · 2023 · Letter
Sentilhes L, Allart JB, Berveiller P, Bibes A, et al.
📚 5 cit.🔬→🩺 Translationnel
Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
RMD open · 2022 · Observational Study
De La Fuente F, Belkhir R, Henry J, Nguyen CD, et al.
📚 13 cit.🎯 RCR 1.15🩺 Clinique
Interleukin-1β-Activated Microvascular Endothelial Cells Promote DC-SIGN-Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · Journal Article
Laurent P, Lapoirie J, Leleu D, Levionnois E, et al.
📚 18 cit.🎯 RCR 1.53🔬→🩺 Translationnel
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
European journal of cancer (Oxford, England : 1990) · 2021 · Journal Article
Kostine M, Mauric E, Tison A, Barnetche T, et al.
📚 80 cit.🎯 RCR 4.14🔬→🩺 Translationnel
Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study
Rheumatology (Oxford, England) · 2021 · Clinical Trial, Phase IV
Aouad K, Gaudin P, Vittecoq O, Morel J, et al.
📚 5 cit.🩺 Clinique
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
Annals of the rheumatic diseases · 2021 · Journal Article
Laurent P, Allard B, Manicki P, Jolivel V, et al.
📚 38 cit.🎯 RCR 2.05🔬→🩺 Translationnel
Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort
Rheumatology (Oxford, England) · 2021 · Journal Article
Combe B, Rincheval N, Berenbaum F, Boumier P, et al.
📚 20 cit.🎯 RCR 1.70🔬→🩺 Translationnel
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
Seminars in arthritis and rheumatism · 2021 · Journal Article
Juge PA, Solomon JJ, van Moorsel CHM, Garofoli R, et al.
📚 37 cit.🎯 RCR 2.95🩺 Clinique
Automatic phenotyping of electronical health record: PheVis algorithm
Journal of biomedical informatics · 2021 · Journal Article
Ferté T, Cossin S, Schaeverbeke T, Barnetche T, et al.
📚 15 cit.🎯 RCR 1.45
Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
Revue du rhumatisme (Ed. francaise : 1993) · 2021 · Journal Article
Richez C, Flipo RM, Berenbaum F, Cantagrel A, et al.
Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
Seminars in arthritis and rheumatism · 2021 · Journal Article
Scherlinger M, Lutz J, Galli G, Richez C, et al.
📚 24 cit.🎯 RCR 2.32🩺 Clinique
Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reports
Rheumatology (Oxford, England) · 2021 · Case Reports
El-Hout S, Lopez L, Schaeverbeke T, Richez C, et al.
📚 1 cit.🔬→🩺 Translationnel
Role of stress in the development of rheumatoid arthritis: a case-control study
Rheumatology (Oxford, England) · 2021 · Journal Article
Germain V, Scherlinger M, Barnetche T, Pichon C, et al.
📚 15 cit.🎯 RCR 1.29🔬→🩺 Translationnel
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Annals of the rheumatic diseases · 2021 · Consensus Statement
Kostine M, Finckh A, Bingham CO, Visser K, et al.
📚 196 cit.🎯 RCR 13.91🩺 Clinique
'To switch or not to switch': the missing piece in the puzzle of biosimilar literature?
Annals of the rheumatic diseases · 2020 · Letter
Scherlinger M, Schaeverbeke T
📚 8 cit.
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
Joint bone spine · 2020 · Journal Article
Richez C, Flipo RM, Berenbaum F, Cantagrel A, et al.
📚 16 cit.
Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis
The Journal of investigative dermatology · 2020 · Journal Article
Henrot P, Moisan F, Laurent P, Manicki P, et al.
📚 16 cit.🎯 RCR 1.10🔬→🩺 Translationnel
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
Autoimmunity reviews · 2020 · Journal Article
Scherlinger M, Mertz P, Sagez F, Meyer A, et al.
📚 111 cit.🎯 RCR 5.86🔬→🩺 Translationnel
A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort
Rheumatology (Oxford, England) · 2020 · Journal Article
Carvajal Alegria G, Milin M, Gandjbakhch F, Saraux A, et al.
📚 2 cit.
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
The Journal of rheumatology · 2020 · Journal Article
Maksymowych WP, FitzGerald O, Østergaard M, Homik J, et al.
📚 3 cit.
Implications du COVID-19 pour la prise en charge des rhumatismes inflammatoires chroniques
Revue du rhumatisme (Ed. francaise : 1993) · 2020 · Editorial
Richez C, Lazaro E, Lemoine M, Truchetet ME, et al.
Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
Joint bone spine · 2020 · Editorial
Richez C, Lazaro E, Lemoine M, Truchetet ME, et al.
📚 24 cit.🎯 RCR 1.38🔬→🩺 Translationnel

Biothérapies non-anti-TNF5

▼

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
Rheumatology (Oxford, England) · 2024 · Journal Article
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, et al.
📚 2 cit.
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · Randomized Controlled Trial
Kedra J, Dieudé P, Giboin C, Marotte H, et al.
📚 3 cit.🩺 Clinique
Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels
Joint bone spine · 2022 · Letter
Marotte H, Fakra E, Flipo RM, Schaeverbeke T, et al.
📚 1 cit.
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
Rheumatology (Oxford, England) · 2022 · Comparative Study
Rempenault C, Lukas C, Combe B, Herrero A, et al.
📚 28 cit.🎯 RCR 2.70
Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients
The Journal of rheumatology · 2021 · Journal Article
Clément J, Duffau P, Constans J, Schaeverbeke T, et al.
📚 18 cit.🎯 RCR 1.53🩺 Clinique

Essai clinique4

▼

Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)
Rheumatology (Oxford, England) · 2021 · Journal Article
Molto A, Gossec L, Poiraudeau S, Claudepierre P, et al.
📚 20 cit.🎯 RCR 1.84🩺 Clinique
GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
BMJ open · 2020 · Journal Article
Couderc M, Pereira B, Schaeverbeke T, Thomas T, et al.
📚 13 cit.🩺 Clinique
Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial
Seminars in arthritis and rheumatism · 2020 · Journal Article
Molto A, Gossec L, Poiraudeau S, Claudepierre P, et al.
📚 6 cit.🩺 Clinique
Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort
Rheumatology (Oxford, England) · 2020 · Journal Article
Mariette X, Perrodeau E, Verner C, Struillou X, et al.
📚 21 cit.🎯 RCR 1.29🩺 Clinique

Stratégie thérapeutique3

▼

Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM
Rheumatology (Oxford, England) · 2023 · Journal Article
Ramiro S, Landewé R, van der Heijde D, Sepriano A, et al.
📚 10 cit.🎯 RCR 1.82🔬→🩺 Translationnel
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort
The Journal of rheumatology · 2020 · Clinical Trial
Sepriano A, Ramiro S, FitzGerald O, Østergaard M, et al.
📚 19 cit.🎯 RCR 1.29🩺 Clinique
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)
Annals of the rheumatic diseases · 2020 · Journal Article
Ramiro S, Landewé RB, van der Heijde D, Sepriano A, et al.
📚 51 cit.🎯 RCR 3.46🔬→🩺 Translationnel

Anti-TNF2

▼

Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
Advances in therapy · 2025 · Journal Article
Marotte H, Cantagrel A, Coury F, Schaeverbeke T, et al.
📚 2 cit.🩺 Clinique
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology (Oxford, England) · 2025 · Journal Article
Nguyen Y, Baron G, Hamamouche N, Belkhir R, et al.
📚 1 cit.🩺 Clinique

csDMARDs2

▼

METHOFRACT, a methotrexate osteopathy multicentre cohort study
RMD open · 2025 · Journal Article
Robin F, Ghossan R, Mehsen-Cetre N, Triquet L, et al.
📚 2 cit.
Methotrexate and rheumatoid arthritis associated interstitial lung disease
The European respiratory journal · 2021 · Journal Article
Juge PA, Lee JS, Lau J, Kawano-Dourado L, et al.
📚 170 cit.🎯 RCR 14.58🔬→🩺 Translationnel

Case report / série1

▼

JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
European journal of clinical pharmacology · 2022 · Journal Article
Gouverneur A, Avouac J, Prati C, Cracowski JL, et al.
📚 24 cit.🎯 RCR 2.27🔬→🩺 Translationnel

Épidémiologie & registres1

▼

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry
Rheumatology (Oxford, England) · 2024 · Journal Article
Faganello D, Bertrand A, Meunier P, Avouac J, et al.
📚 2 cit.

JAK inhibiteurs1

▼

Treatment patterns in patients with rheumatoid arthritis initiating a JAK inhibitor or a TNF inhibitor based on retail pharmacies drug-dispensing data
Joint bone spine · 2023 · Letter
Sambourg J, Gouverneur A, Bardoulat I, Schaeverbeke T, et al.
📚 2 cit.

Lupus1

▼

Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis
Science translational medicine · 2021 · Journal Article
Scherlinger M, Guillotin V, Douchet I, Vacher P, et al.
📚 45 cit.🎯 RCR 2.77🔬→🩺 Translationnel

Microbiote1

▼

Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
Microbiology spectrum · 2023 · Journal Article
Enaud R, Lussac-Sorton F, Charpentier E, Velo-Suárez L, et al.
📚 11 cit.🎯 RCR 1.56

Ostéomalacie1

▼

Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025 · Journal Article
Lasnier-Siron J, Perret R, Jaafar A, Schaeverbeke T, et al.
📚 1 cit.

Qualité de vie / PROMs1

▼

GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
BMJ open · 2020 · Journal Article
Couderc M, Pereira B, Schaeverbeke T, Thomas T, et al.
📚 13 cit.🩺 Clinique

Revue / méta-analyse1

▼

The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis
Rheumatology (Oxford, England) · 2022 · Comparative Study
Lopez L, Griffier R, Barnetche T, Lhomme E, et al.
📚 4 cit.🔬→🩺 Translationnel

Datasets & protocoles partagés

Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).

Partager cette fiche

in LinkedIn 🟢 WhatsApp ✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.